NasdaqCM:CHFS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy. More Details


Snowflake Analysis

Adequate balance sheet with limited growth.


Similar Companies

Share Price & News

How has CHF Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CHFS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-8.7%

CHFS

0.09%

US Medical Equipment

-1.1%

US Market


1 Year Return

-77.3%

CHFS

22.2%

US Medical Equipment

15.6%

US Market

Return vs Industry: CHFS underperformed the US Medical Equipment industry which returned 22.2% over the past year.

Return vs Market: CHFS underperformed the US Market which returned 15.6% over the past year.


Shareholder returns

CHFSIndustryMarket
7 Day-8.7%0.09%-1.1%
30 Day-26.8%6.5%4.2%
90 Day-71.6%5.8%6.3%
1 Year-77.3%-77.3%23.3%22.2%18.2%15.6%
3 Year-99.8%-99.8%75.4%70.7%39.6%30.4%
5 Year-100.0%-100.0%138.9%120.1%79.5%59.2%

Price Volatility Vs. Market

How volatile is CHF Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CHF Solutions undervalued compared to its fair value and its price relative to the market?

0.96x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate CHFS's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate CHFS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CHFS is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: CHFS is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CHFS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CHFS is good value based on its PB Ratio (1x) compared to the US Medical Equipment industry average (4x).


Next Steps

Future Growth

How is CHF Solutions forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

36.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CHFS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CHFS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CHFS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CHFS's revenue (56.8% per year) is forecast to grow faster than the US market (10% per year).

High Growth Revenue: CHFS's revenue (56.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CHFS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has CHF Solutions performed over the past 5 years?

2.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CHFS is currently unprofitable.

Growing Profit Margin: CHFS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CHFS is unprofitable, but has reduced losses over the past 5 years at a rate of 2.3% per year.

Accelerating Growth: Unable to compare CHFS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CHFS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.9%).


Return on Equity

High ROE: CHFS has a negative Return on Equity (-181.7%), as it is currently unprofitable.


Next Steps

Financial Health

How is CHF Solutions's financial position?


Financial Position Analysis

Short Term Liabilities: CHFS's short term assets ($11.7M) exceed its short term liabilities ($3.3M).

Long Term Liabilities: CHFS's short term assets ($11.7M) exceed its long term liabilities ($206.0K).


Debt to Equity History and Analysis

Debt Level: CHFS is debt free.

Reducing Debt: CHFS has no debt compared to 5 years ago when its debt to equity ratio was 31.6%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CHFS has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CHFS has less than a year of cash runway if free cash flow continues to grow at historical rates of 8.9% each year.


Next Steps

Dividend

What is CHF Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CHFS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CHFS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CHFS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CHFS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CHFS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.2yrs

Average management tenure


CEO

John Erb (71 yo)

4.92yrs

Tenure

US$579,758

Compensation

Mr. John L. Erb has been the Chief Executive Officer of CHF Solutions, Inc. (also known as Sunshine Heart Inc.) since November 2015 and served as its President since November 2015 until July 1, 2020. Mr. E ...


CEO Compensation Analysis

Compensation vs Market: John's total compensation ($USD579.76K) is about average for companies of similar size in the US market ($USD585.94K).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
John Erb
Chairman of the Board & CEO4.92yrsUS$579.76k0.015%
$ 2.7k
Nestor Jaramillo
President & COO0.25yrUS$639.84k0%
$ 0
Claudia Drayton
CFO & Principal Accounting Officer5.75yrsUS$392.42k0.000040%
$ 7.0
David Lerner
Chief Technology Officer1.58yrsno datano data
Thomas Lynch
Chief Legal and Compliance Officer & Secretary2.17yrsno datano data
Sandra Eayrs
Senior Vice President of Human Resources5.75yrsno datano data
Vitaliy Epshteyn
Sr. Vice President of Operations & Engineering0.25yrno datano data
Carrie Powers
Senior Vice President of Commercial Operations2yrsno datano data
Laurent Duhoux
Vice President of International Business Development2.17yrsno datano data

2.2yrs

Average Tenure

52.5yo

Average Age

Experienced Management: CHFS's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
John Erb
Chairman of the Board & CEO4.92yrsUS$579.76k0.015%
$ 2.7k
Gregory Waller
Independent Director9.17yrsUS$64.26k0.000040%
$ 7.0
Warren Watson
Lead Independent Directorno dataUS$71.76k0.000040%
$ 7.0
Jon Salveson
Independent Non Executive Director7.58yrsUS$59.01k0.000040%
$ 7.0
Steven Brandt
Independent Non-Executive Director3.67yrsUS$133.60k0.000040%
$ 7.0
Maria Costanzo
Independent Director1.08yrsUS$18.38kno data

7.6yrs

Average Tenure

66.5yo

Average Age

Experienced Board: CHFS's board of directors are considered experienced (7.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 2275.6%.


Top Shareholders

Company Information

CHF Solutions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CHF Solutions, Inc.
  • Ticker: CHFS
  • Exchange: NasdaqCM
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$17.565m
  • Shares outstanding: 2.74m
  • Website: https://www.chf-solutions.com

Number of Employees


Location

  • CHF Solutions, Inc.
  • 12988 Valley View Road
  • Eden Prairie
  • Minnesota
  • 55344
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CHFSNasdaqCM (Nasdaq Capital Market)YesOrdinary SharesUSUSDFeb 2012
22S4DB (Deutsche Boerse AG)YesOrdinary SharesDEEURFeb 2012

Biography

CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy. The company’s commercial product is the Aquadex FlexFlow Sy ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/27 00:16
End of Day Share Price2020/10/26 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.